Literature DB >> 21193332

A critical evaluation of the impact of Leapfrog's evidence-based hospital referral.

Nader N Massarweh1, David R Flum, Rebecca G Symons, Thomas K Varghese, Carlos A Pellegrini.   

Abstract

BACKGROUND: Evidence-based hospital referral (EBHR) is a Leapfrog group quality metric based primarily on hospital procedural volume. It has yet to be determined if EBHR has led to regionalized surgical care and whether it has improved patient outcomes. STUDY
DESIGN: We conducted a before and after cohort study of 13,157 adults (1994 to 2007) who underwent pancreatic or esophageal resection or abdominal aortic aneurysm (AAA) repair in Washington State. Adjusted mortality, readmission, and complication rates were assessed before and after EBHR was introduced.
RESULTS: Hospitals meeting an EBHR volume metric in any year ranged from 2 to 6. Comparing before and after 2001 (2004 for pancreatic resection), the proportion of patients treated at hospitals meeting the EBHR volume metric for a given procedure increased for pancreatic (59.4% vs 75.7%, p < 0.001) and esophageal resection (41.5% vs 59.2%, p < 0.001), but was similar for AAA repair (16.3% vs 17.6%, p = 0.13). In general, rates of adverse events were lower at hospitals meeting an EBHR volume metric. However, across Washington State and at non-EBHR centers, rates of mortality, readmission, and complications generally did not improve in the 7 years after introduction of the EBHR initiative.
CONCLUSIONS: Although a greater proportion of pancreatic or esophageal resections were performed at hospitals meeting a given EBHR volume metric in the 7 years after Leapfrog, this shift had a negligible impact on outcomes across Washington State. It remains to be determined why regionalization for AAA repair has not occurred and why regionalization trends in pancreatic and esophageal surgery have not had the intended impact of improving overall safety outcomes.
Copyright © 2011 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21193332     DOI: 10.1016/j.jamcollsurg.2010.09.027

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  7 in total

1.  Pancreaticoduodenectomy: outcomes in a low-volume, specialised Hepato Pancreato Biliary unit.

Authors:  H A Kanhere; M I Trochsler; M H Kanhere; A N Lord; G J Maddern
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

2.  Reliability of surgical outcomes for predicting future hospital performance.

Authors:  Robert W Krell; Douglas O Staiger; Justin B Dimick
Journal:  Med Care       Date:  2014-06       Impact factor: 2.983

Review 3.  Volume-outcome relationship in surgery for esophageal malignancy: systematic review and meta-analysis 2000-2011.

Authors:  Sheraz R Markar; Alan Karthikesalingam; Sri Thrumurthy; Donald E Low
Journal:  J Gastrointest Surg       Date:  2011-11-17       Impact factor: 3.452

4.  Evolution of standardized clinical pathways: refining multidisciplinary care and process to improve outcomes of the surgical treatment of esophageal cancer.

Authors:  Sheraz R Markar; Henner Schmidt; Sonia Kunz; Artur Bodnar; Michal Hubka; Donald E Low
Journal:  J Gastrointest Surg       Date:  2014-04-29       Impact factor: 3.452

5.  Minimum volume standards in German hospitals: do they get along with procedure centralization? A retrospective longitudinal data analysis.

Authors:  Werner de Cruppé; Marc Malik; Max Geraedts
Journal:  BMC Health Serv Res       Date:  2015-07-22       Impact factor: 2.655

Review 6.  A systematic review of the impact of center volume in dialysis.

Authors:  Dawid Pieper; Tim Mathes; Mark Roger Marshall
Journal:  BMC Res Notes       Date:  2015-12-22

7.  Validation of administrative hospital data for identifying incident pancreatic and periampullary cancer cases: a population-based study using linked cancer registry and administrative hospital data in New South Wales, Australia.

Authors:  Nicola Creighton; Richard Walton; David Roder; Sanchia Aranda; David Currow
Journal:  BMJ Open       Date:  2016-07-01       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.